AIGISRX ANTIBACTERIAL ENVELOPE
Report
- Report Number
- 3005619263-2012-00001
- Event Type
- Injury
- Date Received
- December 6, 2012
- Date of Event
- September 7, 2011
- Report Date
- October 22, 2012
- Manufacturer
- TYRX INC.
- Product Code
- FTL
- PMA / PMN Number
- K063091
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MI, US
- Reporter Occupation
- PHYSICIAN
Narratives
THIS MDR IS SUBMITTED AS NO CLEAR ROOT CAUSE COULD BE DETERMINED AND THE ROLE OF AIGIS CANNOT BE RULED OUT. THE EVENT WAS REPORTED TO THE COMPANY BY A COMPANY CLINICAL MONITOR AS PART OF A ROUTINE F/U FOR A POST-MARKETING STUDY. IT IS BELIEVED THAT NO PRODUCT COMPLAINT WAS FILED BY THE CLINICAL SITE. THE CLINICIAN WAS UNAVAILABLE FOR DIRECT INTERVIEW. THE SUPPORT STAFF WAS NOT PRESENT AT THE TIME OF THE IMPLANT OR EXPLANT, SO COULD PROVIDE NO FURTHER DETAILS. IN THE COMPANY¿S OPINION, THE ROLE OF THE AIGIS DEVICE IN THIS EVENT CANNOT BE RULED OUT. EROSION WAS REPORTED NEAR THE SURGICAL SITE FOR THE COMBINED IMPLANTATION OF THE AIGISRX ANTIBACTERIAL ENVELOPE AND CIED. NO INFECTION WAS REPORTED UNTIL AFTER DEHISCENCE AND EXPOSURE OF THE METAL CAN OCCURRED. REMOVAL OF BOTH THE AIGISRX ANTIBACTERIAL ENVELOPE AND CIED FOLLOWED BY INTRAVENOUS VANCOMYCIN ALLOWED THE PT TO SUBSEQUENTLY RECOVER. NO ENDOCARDITIS WAS OBSERVED. THE COMPANY WILL CONTINUE TO MONITOR ANY REPORTS OF PRODUCT SAFETY AND PERFORMANCE.
PT RECEIVED AIGIS ICD ON (B)(6) 2011 AND WAS EXPLANTED ON (B)(6) 2011. IT WAS REPORTED THE PT DEVELOPED EROSION AT THE SURGICAL SITE WITH DEHISCENCE AND EXPOSURE OF THE CIED. SUBSEQUENTLY, AN INFECTION DEVELOPED. THE CIED AND AIGIS DEVICE WERE EXPLANTED. THE LEADS APPEAR TO HAVE BEEN LEFT IN PLACE. PT RECEIVED IV VANCOMYCIN FOR 12 DAYS. ENDOCARDITIS WAS NOT OBSERVED. PT SUBSEQUENTLY RECOVERED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | AIGISRX ANTIBACTERIAL ENVELOPE | AIGIS | FTL | TYRX INC. | ICD | 11C08214 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 54 YR | Hospitalization| L| R | CIED DEVICE - MFR AND MODEL UNK |